← All stocks

UNITED THERAPEUTICS Corp

UTHR Mostly scheduled
CIK 0001082554 #683 in the set updated 17 Sep 2026
Bought (120 mo)
$866.37K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.34B
$1.32M on a plan · $2.33B straight out of an exercise
Sold at will
$11.82M
52 of 5265 sales
Net
−$2.34B
−$10.95M against sales at will

By person

16 insiders · 5,561 transactions
122×

Martine Rothblatt holds 122 times base salary in stock. $188.72M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $504.57, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ROTHBLATT MARTINE A
Chairperson & CEO
$863.95K (1)
$1.39B (3632) scheduled
−$1.39B
374,024
0.8720%
$188.72M
−4.6%
BENKOWITZ MICHAEL
PRESIDENT AND COO
$350.42M (484) scheduled
−$350.42M
21,623
0.0504%
$10.91M
−83.4%
EDGEMOND JAMES
CFO AND TREASURER
$263.38M (443) scheduled
−$263.38M
18,876
0.0440%
$9.52M
+983.6%
MAHON PAUL A
EVP & GENERAL COUNSEL
$240.78M (492) scheduled
−$240.78M
45,172
0.1053%
$22.79M
−32.4%
SULLIVAN LOUIS W
Director
$17.75M (39) scheduled
−$17.75M
2,983
0.0070%
$1.51M
−0.3%
CAUSEY CHRISTOPHER
Director
$14.53M (38) scheduled
−$14.53M
4,190
0.0098%
$2.11M
+275.8%
Olian Judy D.
Director
$13.41M (25) scheduled
−$13.41M
5,555
0.0130%
$2.80M
PATUSKY CHRISTOPHER
Director
$2.42K (5)
$11.43M (33) scheduled
−$11.42M
3,240
0.0076%
$1.63M
+150.0%
Thompson Tommy G
Director
$10.92M (18) scheduled
−$10.92M
18,270
0.0426%
$9.22M
Giltner Richard
Director
$8.12M (10) scheduled
−$8.12M
21,884
0.0510%
$11.04M
DWEK RAYMOND
Director
$7.24M (15) scheduled
−$7.24M
1,750
0.0041%
$883.00K
KURZWEIL RAY
Director
$7.16M (10) scheduled
−$7.16M
13,320
0.0311%
$6.72M
Mesa Nilda
Director
$1.54M (15)
−$1.54M
5,580
0.0130%
$2.82M
MALCOLM JAN
Director
$653.61K (10) scheduled
−$653.61K
450
0.0010%
$227.06K
MAXWELL LINDA
Director
$456.00K (1) scheduled
−$456.00K
0
0.0000%
$0.00
Klein Katherine J
Director
3,640
0.0085%
$1.84M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1,202
Amendments (4/A) skipped 25
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 5,197
Sales at will 52
Transactions with no price 0
Shares from compensation/vesting 10,066,234
Sales filed before the plan box existed 31
History held since 2 Sep 2016